{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:41:40Z","timestamp":1769560900248,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000055","name":"U.S. Department of Health & Human Services | NIH | National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","award":["DC020172"],"award-info":[{"award-number":["DC020172"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-01322-7","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T15:36:03Z","timestamp":1767022563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of mucosal immune dysregulation and safety and tolerability of endoscopic topical steroid therapy for long-COVID hyposmia: randomized, double-blinded pilot study"],"prefix":"10.1038","volume":"6","author":[{"given":"Sarah","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent M.","family":"D\u2019Anniballe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3038-1276","authenticated-orcid":false,"given":"John B.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Jang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Abi-Hachem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9612-1696","authenticated-orcid":false,"given":"Bradley J.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"1322_CR1","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1038\/s41591-024-03173-6","volume":"30","author":"Z Al-Aly","year":"2024","unstructured":"Al-Aly, Z. et al. Long COVID science, research and policy. Nat. Med. 30, 2148\u20132164 (2024).","journal-title":"Nat. Med."},{"key":"1322_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.12.1074","author":"C Skevaki","year":"2024","unstructured":"Skevaki, C. et al. Long COVID: Pathophysiology, current concepts, and future directions. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2024.12.1074 (2024).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1322_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/S0140-6736(22)01214-4","volume":"400","author":"AV Ballering","year":"2022","unstructured":"Ballering, A. V., van Zon, S. K. R., Olde Hartman, T. C., Rosmalen, J. G. M. & Lifelines Corona Research, I. Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study. Lancet 400, 452\u2013461 (2022).","journal-title":"Lancet"},{"key":"1322_CR4","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41590-023-01601-2","volume":"24","author":"AD Proal","year":"2023","unstructured":"Proal, A. D. et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat. Immunol. 24, 1616\u20131627 (2023).","journal-title":"Nat. Immunol."},{"key":"1322_CR5","doi-asserted-by":"publisher","first-page":"199157","DOI":"10.1016\/j.virusres.2023.199157","volume":"334","author":"KDE Bernal","year":"2023","unstructured":"Bernal, K. D. E. & Whitehurst, C. B. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res. 334, 199157 (2023).","journal-title":"Virus Res."},{"key":"1322_CR6","doi-asserted-by":"publisher","first-page":"e29864","DOI":"10.1002\/jmv.29864","volume":"96","author":"M Maes","year":"2024","unstructured":"Maes, M., Almulla, A. F., Tang, X., Stoyanova, K. & Vojdani, A. From human herpes virus-6 reactivation to autoimmune reactivity against tight junctions and neuronal antigens, to inflammation, depression, and chronic fatigue syndrome due to Long COVID. J. Med. Virol. 96, e29864 (2024).","journal-title":"J. Med. Virol."},{"key":"1322_CR7","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","volume":"185","author":"Y Su","year":"2022","unstructured":"Su, Y. et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell 185, 881\u2013895.e820 (2022).","journal-title":"Cell"},{"key":"1322_CR8","doi-asserted-by":"publisher","first-page":"e00402","DOI":"10.1128\/mbio.00402-22","volume":"13","author":"X Wu","year":"2022","unstructured":"Wu, X. et al. Viral Mimicry of Interleukin-17A by SARS-CoV-2 ORF8. mBio 13, e00402\u2013e00422 (2022).","journal-title":"mBio"},{"key":"1322_CR9","doi-asserted-by":"publisher","unstructured":"Gultom, M. et al. Sustained vascular inflammatory effects of SARS-CoV-2 Spike protein on human endothelial cells. Inflammation https:\/\/doi.org\/10.1007\/s10753-024-02208-x (2024).","DOI":"10.1007\/s10753-024-02208-x"},{"key":"1322_CR10","doi-asserted-by":"publisher","unstructured":"Brann, D. H. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmia. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abc5801 (2020).","DOI":"10.1126\/sciadv.abc5801"},{"key":"1322_CR11","doi-asserted-by":"publisher","first-page":"5932","DOI":"10.1016\/j.cell.2021.10.027","volume":"184","author":"M Khan","year":"2021","unstructured":"Khan, M. et al. Visualizing in deceased COVID-19 patients how SARS-CoV-2 attacks the respiratory and olfactory mucosae but spares the olfactory bulb. Cell 184, 5932\u20135949.e5915 (2021).","journal-title":"Cell"},{"key":"1322_CR12","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1002\/cne.24105","volume":"525","author":"JE Schwob","year":"2017","unstructured":"Schwob, J. E. et al. Stem and progenitor cells of the mammalian olfactory epithelium: taking poietic license.  J. Comp. Neurol. 525, 1034\u20131054 (2017).","journal-title":"J. Comp. Neurol."},{"key":"1322_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.stem.2019.08.011","volume":"25","author":"M Chen","year":"2019","unstructured":"Chen, M., Reed, R. R. & Lane, A. P. Chronic inflammation directs an olfactory stem cell functional switch from neuroregeneration to immune defense. Cell Stem Cell 25, 501\u2013513.e505 (2019).","journal-title":"Cell Stem Cell"},{"key":"1322_CR14","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/j.it.2024.10.005","volume":"45","author":"MN Ullah","year":"2024","unstructured":"Ullah, M. N., Rowan, N. R. & Lane, A. P. Neuroimmune interactions in the olfactory epithelium: maintaining a sensory organ at an immune barrier interface. Trends Immunol. 45, 987\u20131000 (2024).","journal-title":"Trends Immunol."},{"key":"1322_CR15","doi-asserted-by":"publisher","first-page":"eadd0484","DOI":"10.1126\/scitranslmed.add0484","volume":"14","author":"JB Finlay","year":"2022","unstructured":"Finlay, J. B. et al. Persistent post-COVID-19 smell loss is associated with immune cell infiltration and altered gene expression in olfactory epithelium. Sci. Transl. Med. 14, eadd0484 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1322_CR16","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1126\/science.6505700","volume":"226","author":"RL Doty","year":"1984","unstructured":"Doty, R. L. et al. Smell identification ability: changes with age. Science 226, 1441\u20131443 (1984).","journal-title":"Science"},{"key":"1322_CR17","doi-asserted-by":"publisher","unstructured":"Oliva, A. D. et al. Aging-related olfactory loss is associated with olfactory stem cell transcriptional alterations in humans. J. Clin. Invest. https:\/\/doi.org\/10.1172\/jci155506 (2022).","DOI":"10.1172\/jci155506"},{"key":"1322_CR18","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41593-020-0587-9","volume":"23","author":"MA Durante","year":"2020","unstructured":"Durante, M. A. et al. Single-cell analysis of olfactory neurogenesis and differentiation in adult humans. Nat. Neurosci. 23, 323\u2013326 (2020).","journal-title":"Nat. Neurosci."},{"key":"1322_CR19","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/s41590-023-01724-6","volume":"25","author":"K Yin","year":"2024","unstructured":"Yin, K. et al. Long COVID manifests with T cell dysregulation, inflammation and an uncoordinated adaptive immune response to SARS-CoV-2. Nat. Immunol. 25, 218\u2013225 (2024).","journal-title":"Nat. Immunol."},{"key":"1322_CR20","doi-asserted-by":"publisher","first-page":"D419","DOI":"10.1093\/nar\/gkx760","volume":"46","author":"M Shugay","year":"2018","unstructured":"Shugay, M. et al. VDJdb: a curated database of T-cell receptor sequences with known antigen specificity. Nucleic Acids Res. 46, D419\u2013d427 (2018).","journal-title":"Nucleic Acids Res."},{"key":"1322_CR21","doi-asserted-by":"publisher","first-page":"eabq3059","DOI":"10.1126\/scitranslmed.abq3059","volume":"14","author":"JJ Frere","year":"2022","unstructured":"Frere, J. J. et al. SARS-CoV-2 infection in hamsters and humans results in lasting and unique systemic perturbations after recovery. Sci. Transl. Med. 14, eabq3059 (2022).","journal-title":"Sci. Transl. Med."},{"key":"1322_CR22","doi-asserted-by":"publisher","first-page":"123341","DOI":"10.1016\/j.ijpharm.2023.123341","volume":"644","author":"H Chiang","year":"2023","unstructured":"Chiang, H., Martin, H. L., Sicard, R. M. & Frank-Ito, D. O. Olfactory drug delivery with intranasal sprays after nasal midvault reconstruction. Int. J. Pharm. 644, 123341 (2023).","journal-title":"Int. J. Pharm."},{"key":"1322_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/19458924231218037","volume":"38","author":"A Mahadev","year":"2024","unstructured":"Mahadev, A., Kallogjeri, D. & Piccirillo, J. F. Validation of minimal clinically important difference (MCID) for University of Pennsylvania Smell Identification Test (UPSIT). Am. J. Rhinol. Allergy 38, 123\u2013132 (2024).","journal-title":"Am. J. Rhinol. Allergy"},{"key":"1322_CR24","doi-asserted-by":"publisher","first-page":"673","DOI":"10.7326\/M18-0775","volume":"170","author":"B Liu","year":"2019","unstructured":"Liu, B. et al. Relationship between poor olfaction and mortality among community-dwelling older adults: a cohort study. Ann. Intern. Med. 170, 673\u2013681 (2019).","journal-title":"Ann. Intern. Med."},{"key":"1322_CR25","doi-asserted-by":"publisher","first-page":"e069503","DOI":"10.1136\/bmj-2021-069503","volume":"378","author":"BKJ Tan","year":"2022","unstructured":"Tan, B. K. J. et al. Prognosis and persistence of smell and taste dysfunction in patients with covid-19: meta-analysis with parametric cure modelling of recovery curves. BMJ 378, e069503 (2022).","journal-title":"BMJ"},{"key":"1322_CR26","doi-asserted-by":"publisher","first-page":"103299","DOI":"10.1016\/j.amjoto.2021.103299","volume":"43","author":"JJ Lee","year":"2022","unstructured":"Lee, J. J. et al. Smell changes and efficacy of nasal theophylline (SCENT) irrigation: a randomized controlled trial for treatment of post-viral olfactory dysfunction. Am. J. Otolaryngol. 43, 103299 (2022).","journal-title":"Am. J. Otolaryngol."},{"key":"1322_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaoto.2025.1304","volume":"151","author":"NF Farrell","year":"2025","unstructured":"Farrell, N. F. et al. Stellate ganglion block for the treatment of COVID-19\u2212induced parosmia: a randomized clinical trial. JAMA Otolaryngol. Head. Neck Surg. 151, 741\u2013749 (2025).","journal-title":"JAMA Otolaryngol. Head. Neck Surg."},{"key":"1322_CR28","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1002\/alr.23505","volume":"15","author":"M Fieux","year":"2025","unstructured":"Fieux, M., Castro, B. R., Jang, S. S., Yan, C. H. & Patel, Z. M. Long-term outcomes of PRP injections for post-viral olfactory loss: a prospective cohort study. Int. Forum Allergy Rhinol. 15, 420\u2013427 (2025).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"1322_CR29","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/alr.22788","volume":"11","author":"C Huart","year":"2021","unstructured":"Huart, C. et al. Systemic corticosteroids in coronavirus disease 2019 (COVID-19)-related smell dysfunction: an international view. Int. Forum Allergy Rhinol. 11, 1041\u20131046 (2021).","journal-title":"Int. Forum Allergy Rhinol."},{"key":"1322_CR30","doi-asserted-by":"publisher","first-page":"839182","DOI":"10.3389\/fpubh.2022.839182","volume":"10","author":"SN Narayanan","year":"2022","unstructured":"Narayanan, S. N. et al. The prevalence and pathophysiology of chemical sense disorder caused by the novel coronavirus. Front. Public Health 10, 839182 (2022).","journal-title":"Front. Public Health"},{"key":"1322_CR31","doi-asserted-by":"publisher","first-page":"794550","DOI":"10.3389\/fmed.2022.794550","volume":"9","author":"NN Nguyen","year":"2022","unstructured":"Nguyen, N. N. et al. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Front. Med. 9, 794550 (2022).","journal-title":"Front. Med."},{"key":"1322_CR32","doi-asserted-by":"publisher","unstructured":"D\u2019Anniballe, V. Kim-D-Anniballe_COVID_TCR (Version 1). Zenodo https:\/\/doi.org\/10.5281\/zenodo.17671956 (2025).","DOI":"10.5281\/zenodo.17671956"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01322-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01322-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T11:05:31Z","timestamp":1769511931000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-01322-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1322"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-01322-7","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"29 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.J.G. is co-founder of Rhino Therapeutics, unrelated to this research. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"60"}}